US20020033177A1 - Inhalant medicator - Google Patents
Inhalant medicator Download PDFInfo
- Publication number
- US20020033177A1 US20020033177A1 US09/998,418 US99841801A US2002033177A1 US 20020033177 A1 US20020033177 A1 US 20020033177A1 US 99841801 A US99841801 A US 99841801A US 2002033177 A1 US2002033177 A1 US 2002033177A1
- Authority
- US
- United States
- Prior art keywords
- medical powder
- medicator
- inflow
- cylindrical
- powder storage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Definitions
- the invention relates to an inhalant medicator suitable to prescribe granular or powdered medicines (medical powder) toward within lungs of a patient by way of breathing action of the patient.
- the inhalant medicator as disclosed in the above Japanese Patent Provisional Publication is generally comprised of a medicator body equipped at one axial end with a capsule housing hole and at the other axial end with an inhalant port, an inflow air passageway formed in the medicator body for flowing air into the capsule housing hole, an outflow air passageway formed in the medicator body for flowing medical powder stored in the capsule of the capsule housing hole together with airflown through the inflow air passageway into the inhalant port, pin insertion holes located at both sides of the capsule housing hole in the axial directions of the capsule housing hole and bored in the medicator body in such a manner as to extend in a radial direction of the medicator body for communicating each of the inflow and outflow air passageways, and a boring tool having pins insertable toward the capsule through the respective pin insertion holes for breaking through the capsule accommodated in the capsule housing hole.
- the capsule is accommodated in the capsule housing hole, and holes, communicating the internal space of the capsule with each of the air passageways, are pricked or punched by means of the boring tool.
- the patient draws his or her breath while taking the inhalant port in his or her mouse, and thus air is flown from the atmospheric side through the inflow air passageway into the capsule.
- the air flow carries and discharges the medical powder stored in the capsule through the outflow air passageway into the inhalant port. In this manner, the medical powder flowing out of the capsule can be inhaled through the inhalant port into the lungs of the patient.
- the conventional inhalant medicator described above is constructed so that a capsule is inserted into a capsule housing hole of a medicator body, and the medical powder stored in the capsule is inhaled by pricking or punching holes in the capsules by way of a boring tool.
- a boring tool For the reasons set forth above, there is the necessity for pin insertion holes and the boring tool. This increases the number of component parts, and induces a complicated structure. Thus, there are some problems, such as increased production costs and increased economical burden of a patient.
- an object of the present invention to provide an inhalant medicator which is capable of reducing production costs by reducing the number of component parts and by simplifying its structure.
- an inhalant medicator comprises a medicator body formed with a cylindrical fit hole opening at one axial end and formed at the other axial end with an inhalant port, an inflow air passageway formed in the medicator body for supplying air into the cylindrical fit hole, an outflow air passageway formed in the medicator body for discharging air from the cylindrical fit hole into the inhalant port, and a medical powder storage cylindrical member having a cylindrical portion defining therein a medical powder storage hole whose internal space stores a medical powder and capable of opening and closing each of the inflow air passageway and the outflow air passageway with respect to the medical powder storage hole by external operation.
- the inhalant medicator as constructed above, under a condition where the inflow air passageway and the outflow air passageway are closed with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside via the air passageways.
- the inflow air passageway and the outflow air passageway are communicated with the medical powder storage hole by operating the medical powder storage cylindrical member. Under these conditions, the patient draws his or her breath while taking the inhalant port in his or her mouse, atmosphere flown into the inflow air passageway flows into the medical powder storage hole, taking the form of air flow.
- the medical powder in the medical powder storage hole can be atomized.
- the mixture of the incoming air and medical powder passes through the outflow air passageway and then flows towards within the inhalant port, and then the mixture is inhaled through the inhalant port into lungs of the patient.
- the inhalant medicator of the invention is constructed by two component parts, namely the medicator body and the medical powder storage cylindrical member, and also it is possible to open and close each of the air passageways with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, thus ensuring a simple structure of the medicator. This reduces production costs. Additionally, even when the medical powder storage hole is filled with granular or powdered medicines in advance, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside.
- At least one medical powder diffusion chamber is formed in the medicator body and located between the cylindrical fit hole and the inhalant port for diffusing the medical powder flowing out of the outflow air passageway.
- the inhalant medicator as constructed above, when the patient draws his or her breath while taking the inhalant port in his or her mouse, the medical powder flowing from the medical powder storage hole via the outflow air passageway can be further diffused through the medical powder diffusion chamber, and thus the medical powder can flow into the inhalant port in a finely atomized fashion.
- the air passageway communicating with the medical powder diffusion chamber is formed to open to the medical powder diffusion chamber at an eccentric position in which the air passageway extends in a tangential direction of the medical powder diffusion chamber.
- the inflow air passageway eccentrically arranged in the tangential direction of the medical powder diffusion chamber produces whirling flow within the medical powder diffusion chamber.
- the medical powder storage cylindrical member is constructed by a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
- the inflow and outflow air passageways can be respectively opened or closed by means of the inflow outlet port and the outflow outlet port by rotating the medical powder storage cylindrical member relative to the medicator body while grasping the knob portion.
- the medical powder storage cylindrical member is constructed by a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
- the inflow and outflow air passageways can be respectively opened or closed through the inflow outlet port and the outflow outlet port by taking out or putting in the medical powder storage cylindrical member relative to the medicator body, while grasping the knob portion.
- a stopper means is provided between the medicator body and the medical powder storage cylindrical member for positioning the medical powder storage cylindrical member at a position where the inflow outlet port is communicated with the inflow air passageway and the outflow outlet port is communicated with the outflow air passageway when operating the medical powder storage cylindrical member.
- the stopper means when operating the medical powder storage cylindrical member, can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other.
- the stopper means when operating the medical powder storage cylindrical member, can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other.
- FIG. 1 is a longitudinal cross-sectional view illustrating a first embodiment of an inhalant medicator made according to the invention.
- FIG. 2 is an enlarged lateral cross-sectional view illustrating a medicator body, a cylindrical portion, an inflow air passageway (an outflow air passageway), and others as viewed from the arrow indicated by II-II shown in FIG. 1.
- FIG. 3 is an enlarged lateral cross-sectional view illustrating a medicator body, an outflow air passageway, and others as viewed from the arrow indicated by III-III shown in FIG. 1.
- FIG. 4 is an enlarged perspective view illustrating the appearance of a medical powder storage cylindrical member.
- FIG. 5 is an enlarged perspective view illustrating an essential part of a stopper mechanism provided at the medicator body and the knob portion of the medical powder storage cylindrical member.
- FIG. 6 is an enlarged lateral cross-sectional view illustrating a state of the air passageway formed in the medicator body and the outlet port formed in the cylindrical portion of the medical powder storage cylindrical member, spaced to each other in the circumferential direction, as viewed from the same position as FIG. 2.
- FIG. 7 is a longitudinal cross-sectional view illustrating the inhalant medicator under a particular condition in which medical powders are inhaled, as viewed from the same position as FIG. 1.
- FIG. 8 is a longitudinal cross-sectional view illustrating a second embodiment of an inhalant medicator made according to the invention.
- FIG. 9 is a longitudinal cross-sectional view illustrating a third embodiment of an inhalant medicator made according to the invention.
- FIG. 10 is an enlarged lateral cross-sectional view illustrating the medicator body, a first outflow air passageway and others, as viewed from the arrow indicated by X-X shown in FIG. 9.
- FIG. 11 is an enlarged lateral cross-sectional view illustrating the medicator body, a second outflow air passageway and others, as viewed from the arrow indicated by XI-XI shown in FIG. 9.
- FIG. 12 is a longitudinal cross-sectional view illustrating the inhalant medicator under a particular condition in which a medical powder is inhaled, as viewed from the same position as FIG. 9.
- FIG. 13 is a longitudinal cross-sectional view illustrating a fourth embodiment of an inhalant medicator made according to the invention.
- FIG. 14 is an enlarged cross-sectional view illustrating an essential part of the inhalant medicator in an engaged state between a C-shaped groove of the cylindrical fit hole and an engaged protruded portion of the medical powder storage cylindrical member, as viewed from the arrow indicated by XIV-XIV shown in FIG. 9.
- FIG. 15 is a longitudinal cross-sectional view illustrating the inhalant medicator in an inhalation state of medical powder with the medical powder storage cylindrical member extracted from the medicator body, as viewed from the same position as FIG. 13.
- FIG. 16 is a longitudinal cross-sectional view illustrating an inhalant medicator corresponding to a first modification of the invention.
- FIG. 17 is a longitudinal cross-sectional view illustrating only a medical powder storage cylindrical member corresponding to a second modification of the invention.
- Reference sign 1 denotes a cylindrical medicator body constructing an essential part of the inhalant medicator.
- the medicator body 1 is formed with a cylindrical fit hole 2 as described later, an inhalant port 3 , an inflow air passageway 5 , an outflow air passageway 6 , and others.
- a portion denoted by reference sign 2 is the cylindrical fit hole formed in the medicator body 1 at one axial end.
- the cylindrical fit hole 2 has an axially extending bore opening at the one axial end face 1 A and having a circular shape in cross section and having a bottom.
- the bottom portion 2 A of the cylindrical fit hole is formed as a spherical surface.
- the bottom portion 2 A of the cylindrical fit hole 2 is formed with an annular recessed groove 2 B.
- the annular recessed groove 2 B is configured so that an annular protruded portion 9 A formed at the tip end portion of a cylindrical portion 9 of a medical powder storage cylindrical member 8 , which will be described later.
- a portion denoted by reference sign 3 is the inhalant port formed at the other axial end of the medicator body 1 .
- the inhalant port 3 is formed and configured in such a manner as to gradually diametrically enlarged in the other axial direction. Additionally, the inner part of the inhalant port 3 is formed with a medical powder diffusion chamber 4 , which will be described later.
- a portion denoted by reference sign 4 is the medical powder diffusion chamber located between the cylindrical fit hole 2 and the inhalant port 3 and formed in the medicator body 1 .
- the medical powder diffusion chamber 4 is formed as a cylindrical space axially extending toward the inhalant port 3 , so that whirling flow is produced by way of air flow of air flowing through the inflow air passageway which will be described later.
- Portions denoted by reference signs 5 , 5 are two inflow air passageways formed in one axial end of the medicator body 1 .
- each of the inflow air passageways 5 is constructed by axially-extending axial passages 5 A, SA located on the outer periphery of the cylindrical fit hole 2 and opening to the atmosphere at the one axial end face 1 A, and radial passages 5 B, 5 B communicating the respective axial passages 5 A and extending in the radial direction of the medicator body 1 and opening to the cylindrical fit bore 2 .
- Portions denoted by reference signs 6 , 6 are two outflow air passageways formed in a substantially middle portion of the medicator body 1 (as viewed from the axial direction of the medicator body).
- Each of the outflow air passageways 6 is constructed by radial air passageways 6 A, 6 A extending in the radial direction of the medicator body 1 and opening to the cylindrical fit hole 2 , and axial passages 6 B, 6 B communicating the respective tip end portions of the radial passages 6 A and extending in two opposite axial directions, and diffusion chamber inflow passages 6 C, 6 C formed as radial passages extending radially from the respective tip end portions of the axial passages 6 B and opening to the diffusion chamber 4 .
- the diffusion chamber inflow passage 6 C of the inflow air passageway 6 opening to the medical powder diffusion chamber 4 , is formed so that its tip end portion opens at an eccentric position in which the inflow passage extends in the tangential direction of the medical powder diffusion chamber 4 .
- air flow flowing through the diffusion chamber inflow passage 6 C into the medical powder diffusion chamber 4 becomes changed or converted into whirling flow, thus finely atomizing a lump of granular or powdered medicines 16 adhered to each other due to aggregation, condensation or the like.
- Portions denoted by reference signs 7 , 7 are two auxiliary air passageways located on the outer periphery of the cylindrical fit hole 2 and formed in the medicator body 1 . As shown in FIG. 3, each of the auxiliary air passageways 7 is provided at a position rotated 90 degrees with respect to the respective air passageways 5 , 6 .
- the auxiliary air passageway 7 is constructed by axial passages 7 A, 7 A located on the outer periphery of the cylindrical fit hole 2 and extending in the axial direction and opening to the atmosphere at the one axial end face 1 A, and diffusion chamber inflow passages 7 B, 7 B formed as radial passages communicating the respective axial passages 7 A and extending in the radial direction of the medicator body 1 and opening to the medical powder diffusion chamber 4 .
- Each of the auxiliary air passageways 7 functions to avoid difficulty in breathing action by increasing a quantity of air flowing through the medicator during breathing action, and to strengthen the whirling flow within the medical powder diffusion chamber 4 .
- the diffusion chamber inflow passage 7 B of the auxiliary air passageway 7 opening to the medical powder diffusion chamber 4 is formed so that its tip end portion opens at an eccentric position in which the inflow passage extends in the tangential direction of the medical powder diffusion chamber 4 , thus producing the whirling flow within the medical powder diffusion chamber 4 by way of air flow flowing into the medical powder diffusion chamber 4 .
- the whirling flow can finely atomize a lump of granular or powdered medicines 16 adhered to each other due to aggregation, condensation or the like.
- a portion denoted by reference sign 8 is a medical powder storage cylindrical member rotatably installed at the opening end of the cylindrical fit hole 2 .
- the medical powder storage cylindrical member 8 is mainly constructed by a cylindrical portion 9 inserted and fitted into the cylindrical fit hole 2 , and a disc-shaped knob portion 10 provided at the base portion of the cylindrical portion 9 .
- the interior of the cylindrical portion 9 is formed as a medical powder storage hole 11 having a bottom and opening towards its tip end.
- the above medical powder storage hole 11 defines a medical powder storage chamber 12 capable of storing the medical powder 16 between the storage hole and the bottom portion 2 A of the cylindrical fit hole 2 by way of fit of the cylindrical portion 9 into the cylindrical fit hole 2 of the medicator body 1 .
- the previously-noted cylindrical portion 9 is formed at its tip end portion with an annular protruded portion 9 A which is fitted into the annular recessed groove 2 B of the cylindrical fit hole 2 . Fitted engagement between the annular recessed groove 2 B and the annular protruded portion 9 A prevents from the medical powder storage cylindrical member 8 from being fallen out.
- the cylindrical portion 9 is formed at a position corresponding to the radial passage 5 B of the inflow air passageway 5 in the axial direction with an inflow outlet port 9 B so that the inflow outlet port extends or penetrates in the radial direction, and is also formed at a position corresponding to the radial passage 6 A of the outflow air passageway 6 in the axial direction with an outflow outlet port 9 C so that the outflow outlet port extends or penetrates in the radial direction.
- the knob portion 10 is abutted-engagement with the one axial end face 1 A of the medicator body 1 in a powder-tight fashion.
- the knob portion is formed on its outer periphery with a knurling portion 10 A serving as a non-slip portion during rotary motion of the medical powder storage cylindrical member 8 .
- the knob portion 10 is formed with atmospheric outlet portions 10 B, 10 B, . . .
- the medical powder storage cylindrical member 8 closes the medical powder storage chamber 12 by rotating the cylindrical portion 9 relative to the medicator body 1 while grasping the knob portion 10 and therefore moving the air passageways 5 and 6 and the outlet ports 9 B and 9 C in the circumferential direction, with the result that the medical powder storage chamber 12 is fully closed.
- the air passageways 5 and 6 are opened to the medical powder storage chamber, with the result that inhalation action of the medical powders can be allowed.
- the atmospheric outlet ports l 0 B formed in the knob portion 10 act to open or close the air passageways 5 and 7 . Therefore, under a condition where the air passageways 5 and 7 are closed by means of the knob portion 10 , it is possible to prevent dusts from flowing from the outside into the air passageways 5 and 7 .
- a portion denoted by 13 is a stopper mechanism serving as a stopper means provided between the medicator body 1 and the medical powder storage cylindrical member 8 .
- the stopper mechanism 13 is constructed by a positioning groove 14 formed in the outer periphery of the medicator body 1 and a protruded portion 15 located on the outer periphery of the knob portion 10 of the medical powder cylindrical member 8 and projected toward the positioning groove 14 .
- the positioning groove 14 is formed with a closed-position recessed portion 14 A which is brought into engagement with the protruded portion 15 at the closed position (see FIG.
- the stopper mechanism 13 permits the air passageways 5 , 6 and 7 to be easily rapidly communicated with the respective outlet ports 9 B, 9 C and 10 B with the rotary action of the medical powder storage cylindrical member 8 relative to the medicator body 1 .
- Reference sign 16 denotes medical powder stored in the cylindrical fit hole 2 .
- the medical powder 16 is formed as powdered or granulated medicines.
- the medical powder 16 is charged into the medical powder storage chamber 12 at a stage where the medical powder storage cylindrical member 8 is installed on the medicator body 1 .
- the inhalant medicator of the embodiment is constructed as previously discussed. Hereinbelow described in detail are the operation of the inhalant medication through which the patient inhales the medical powder, and the flow of air and medical powder during inhalation.
- the medical powder 16 finely atomized within the medical powder diffusion chamber 4 , is discharged into the inhalant port 3 .
- the inhalant medicator can be constructed by two component parts, namely the medicator body 1 and the medical powder storage cylindrical member 8 , thus reducing the number of component parts, and ensuring more simplified inhalator structure and reduced production costs, in comparison with the conventional inhalant medicator.
- the inhalant medicator of the embodiment can be used as a throwaway type.
- the medical powder diffusion chamber 4 is provided between the cylindrical fit hole 2 and the inhalant port 3 . Therefore, it is possible to certainly finely atomize the medical powder 16 . This ensures an enhanced inhalation efficiency of medical powder 16 and an enhanced reliability of the inhalant medicator. Additionally, it is possible to produce whirling flow within the medical powder diffusion chamber 4 , thus more finely atomizing medical powder 16 .
- the stopper mechanism 13 is provided between the medicator body 1 and the medical powder storage cylindrical member 8 , for positioning the medical powder storage cylindrical member at either a closed position for prevention of loss of flow of medical powder 16 and an open position for medication, with rotary operation of the medical powder storage cylindrical member 8 . Therefore, a series of operations for medication can be easily certainly achieved.
- FIG. 8 Hereunder described in reference to FIG. 8 is the second embodiment of the invention.
- the auxiliary air passageways used in the first embodiment are eliminated, and in lieu thereof the inflow and outflow air passageways are increased.
- the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the second embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
- a portion denoted by reference sign 21 is a medicator body of the second embodiment.
- Portions denoted by reference signs 22 , 22 . . . are inflow air passageways formed in the medicator body 21 .
- each of the inflow air passageways 22 is constructed by an axial passage 22 A and a radial passage 22 B.
- the inflow air passageway 22 of the second embodiment is different from the inflow air passageway 5 of the first embodiment, in that four passageways (only three passageways are shown in the drawing) spaced from each other in the circumferential direction are provided.
- each of the outflow air passageways 23 is constructed by a radial passage 23 A, an axial passage 23 B, and a diffusion chamber inflow passage 23 C.
- the outflow air passageway 23 of the second embodiment is different from the outflow air passageway 6 of the first embodiment, in that four passageways (only three passageways are shown in the drawing) spaced from each other in the circumferential direction are provided.
- the second embodiment as constructed above can provide the same effects and operation as the first embodiment.
- the auxiliary air passageways 7 used in the first embodiment are eliminated, and in lieu thereof the four inflow air passageways 22 are provided, thus ensuring increased air flow of air flowing into the medical powder storage chamber 12 .
- the increased air flow can effectively atomize the medical powder 16 .
- the third embodiment is characterized in that a second medical powder diffusion chamber is provided between the cylindrical fit hole and the medical powder diffusion chamber.
- the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the third embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
- a portion denoted by reference sign 31 is a medicator body of the third embodiment. Substantially in the same manner as the medicator body 1 of the first embodiment, the medicator body 31 is formed therein with a cylindrical fit hole 32 , an inhalant port 33 , and others. However, the medicator body 31 of the third embodiment has a first medical powder diffusion chamber 34 and a second medical powder diffusion chamber 35 , both provided between the cylindrical fit hole 32 and the inhalant port 33 . The medicator body of the third embodiment is different from the medicator body 1 of the first embodiment, in that as a whole the medicator body of the third embodiment is formed as a longer body.
- each of the inflow air passageways 36 is constructed by an axial passage 36 A and a radial passage 36 B.
- Portions denoted by reference signs 37 , 37 . . . are two first outflow air passageways.
- Each of the first outflow air passageways 37 is constructed by radial passages 37 A, 37 A extending in the radial direction and opening to the cylindrical fit hole 32 , axial passages 37 B, 37 B, communicating the respective tip end portions of the radial passages 37 A and extending in the axial direction, and diffusion chamber inflow passages 37 C, 37 C formed as radial passages extending in the radial direction from the respective tip end portions of the axial passages 37 B and opening to the first medical powder diffusion chamber 34 .
- Portions denoted by reference signs 38 , 38 . . . are four second outflow air passageways of the third embodiment.
- Each of the second outflow air passageways 38 is constructed by diffusion chamber outflow passages 38 A, 38 A formed as radial passages extending in the radial direction and opening to the first medical powder diffusion chamber 34 , axial passages 38 B, 38 B communicating the respective tip end portions of the diffusion chamber outflow passages 38 A and extending in the axial direction, and diffusion chamber inflow passages 38 C, 38 C formed as radial passages extending in the radial direction from the tip end portions of the axial passages 38 B and opening to the second medical powder diffusion chamber 35 .
- auxiliary air passageways 39 are two auxiliary air passageways of the third embodiment.
- Each of the auxiliary air passageways 39 is constructed by axial passages 39 A, 39 A, and diffusion chamber inflow passages 39 B, 39 B formed as radial passages communicating the respective axial passages 39 A and extending in the radial direction and opening to the first medical powder diffusion chamber 34 .
- the diffusion chamber inflow passage 37 C of the first inflow air passageway 37 opening to the first medical powder diffusion chamber 34 and the diffusion chamber inflow passage 39 B of the auxiliary air passageway 39 are configured so that their tip end portions open at an eccentric position in which the inflow passage extends in the tangential direction of the first medical powder diffusion chamber 34 .
- the diffusion chamber outflow passage 38 A of the second inflow air passageway 38 opening to the first medical powder diffusion chamber 34 is configured, so that its tip end portion opens at an eccentric position in which the outflow passage extends in the tangential direction opposite to the diffusion chamber inflow passage 39 B of the auxiliary air passageway 39 , in order to facilitate the whirling flow produced within the first medical powder diffusion chamber 34 and passing through the diffusion chamber outflow passage 38 A.
- the diffusion chamber inflow passage 38 C of the second outflow air passageway 38 opening to the second medical powder diffusion chamber 35 opens at an eccentric position in which the inflow passage extends in the same tangential direction as the diffusion chamber inflow passage 37 C of the first outflow air passageway 37 and the diffusion chamber inflow passage 39 B of the auxiliary air passageway 39 .
- the third embodiment as constructed above, can provide the same effects and operation as the first embodiment.
- two medical powder diffusion chambers namely the first and second medical powder diffusion chambers 34 and 35 are provided.
- the medical powder 16 includes granulated medicines having a strong condensation property and the granulated medicines are adhered to each other to form a lump of granulated medicines, as can be seen from FIG. 12, it is possible to break and atomize the lump of medical powder by means of the two medical powder diffusion chambers 34 and 35 . As a consequence, it is possible to inhale a specified amount of medical powder into lungs of the patient.
- a medical powder storage cylindrical member is constructed by a cylindrical portion axially slidably fitted into the inner peripheral surface of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
- the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the fourth embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
- a portion denoted by reference sign 41 is a medicator body of the fourth embodiment.
- a portion denoted by reference sign 42 is a cylindrical fit hole formed in the medicator body 41 .
- the cylindrical fit hole 42 has an axially extending bore opening at one axial end 41 A and having a circular shape in cross section and having a bottom.
- the bottom portion 42 A of the cylindrical fit hole is formed as a spherical surface.
- the bottom portion 42 A of the cylindrical fit hole 42 is formed with a C-shaped groove 42 B. As shown in FIG. 14, the C-shaped groove 42 B is configured in such a manner as to guide movably an engaged protruded portion 44 A of a cylindrical portion 44 described later.
- a portion denoted by reference sign 43 is a medical powder storage cylindrical member of the fourth embodiment, installed on the cylindrical fit hole 42 so that the medical powder storage cylindrical member is capable of taking out or putting in with respect to the opening end of the cylindrical fit hole 42 .
- the medical powder storage cylindrical member 43 is mainly constructed by a cylindrical portion 44 inserted and fitted into the cylindrical fit hole 42 , and a disc-shaped knob portion 45 provided at the base portion of the cylindrical portion 44 .
- the interior of the cylindrical portion 44 is formed as a medical powder storage hole 46 .
- a medical powder storage chamber 47 is defined between the medical powder storage hole 46 and the bottom portion 42 A of the cylindrical fit hole 42 .
- the medical powder storage cylindrical member 43 of the fourth embodiment is different from the medical powder storage cylindrical member 43 of the first embodiment, in that the engaged protruded portion 4 A, fitted to the C-shaped groove 42 B of the cylindrical fit hole 42 , is provided at the tip end portion of the cylindrical portion 44 , inflow outlet port 44 B and outflow outlet port 44 C are formed in the cylindrical portion 44 at positions at which the inflow and outflow outlet ports respectively communicate the radial passage 5 B of the inflow air passageway 5 and the radial passage 6 A of the outflow air passageway 6 under a condition where the cylindrical portion 44 is extracted, and the atmospheric outlet ports used in the first embodiment are removed from the knob portion 45 .
- the C-shaped groove 42 B formed in the cylindrical fit hole 42 of the medicator body 41 and the engaged protruded portion 44 A formed in the cylindrical portion 44 of the medical powder storage cylindrical member 43 cooperate to each other to construct a stopper mechanism 48 serving as a stopper means for positioning the medical powder storage cylindrical member 43 during taking-out/putting-in operation of the medical powder storage cylindrical member 43 with respect to the medicator body 41 .
- the inhalant medicator of the fourth embodiment is constructed as previously discussed. Hereinbelow described in detail is the operation of the inhalant medication through which the patient inhales the medical powder.
- the medical powder storage cylindrical member 43 is rotated relative to the medicator body 41 in the direction indicated by the arrow A shown in FIGS. 13 and 14.
- the cylindrical portion 44 of the medical powder storage cylindrical member 43 is extracted in the direction indicated by the arrow B.
- the medical powder storage cylindrical member 43 returns the medical powder storage cylindrical member 43 to the direction indicated by the arrow C, as shown in FIG. 15, it is possible to position in such a manner as to establish fluid communication between the air passageway 5 and the inflow outlet port 44 B and fluid communication between the air passageway 6 and the outflow outlet port 44 C.
- the medical powder 16 can be inhaled.
- the fourth embodiment as constructed above, can provide the same effects and operation as the first embodiment.
- the auxiliary air passageways 39 , 39 through which the first medical powder diffusion chamber is communicated with the atmospheric side is formed in the medicator body 31 .
- the present invention is not limited to the particular embodiments shown and described herein.
- another auxiliary air passageways 39 , 39 (only one passageway is shown in the drawing) intercommunicating the atmospheric side and the second medical powder diffusion chamber 35 , may be formed in the medicator body 31 , independently of the auxiliary air passageways 39 , 39 intercommunicating the atmospheric side and the first medical powder diffusion chamber 34 .
- the inflow air passageway 5 is constructed by the axial passage 5 A and the radial passage 5 B.
- an inflow air passageway 5 ′ is formed so that the inflow air passageway extends in the radial direction and opens to a curved surface of the medicator body 1 .
- such a construction can be applied to the other embodiments.
- one medical powder diffusion chamber 4 is provided, whereas in the second embodiment and the modification two medical powder diffusion chambers 34 , 35 are provided.
- the invention is not limited to the particular embodiments shown and described herein.
- three or more medical powder diffusion chambers may be provided. It is preferable that the number of the medical powder diffusion chambers is determined or set depending on characteristics or properties of medical powder (such as a condensation property).
- the medical powder 16 is encapsulated within the cylindrical fit hole 2 at a time when the medicator body 1 and the medical powder storage cylindrical member 8 are assembled to each other.
- the medical powder 16 may be charged into the cylindrical fit hole 2 just before the operation of inhalant medication. In the same manner, such a construction can be applied to the other embodiments.
- the opening and closing of the inflow air passageways 5 , 22 , 36 with respect to the atmospheric side are made by the respective knob portions 10 , 45 of the medical powder storage cylindrical members 8 , 43 .
- the invention is not limited to the particular embodiments shown and described herein.
- the knob portion is configured to have the same diameter dimension as the cylindrical portion. That is, it is unnecessary to always close the atmospheric outlet port of the inflow air passageway.
- the inflow air passageways 5 , 22 , 36 and the outflow air passageways 6 , 23 , 37 are formed so that these passageways extend in the radial direction towards the central portion of the cylindrical fit holes 2 , 32 , 42 .
- these air passageways may be constructed so that the air passageways open to the respective cylindrical fit holes at eccentric positions in which the air passageways extend in the respective tangential directions of the cylindrical fit holes.
- the medical powder storage chamber 12 is defined between the bottom portion 2 A of the cylindrical fit hole 2 and the medical powder storage hole 11 by fitting the cylindrical portion 9 of the medical powder storage member 8 into the cylindrical fit hole 2 of the medicator body 1 .
- a medical powder storage hole 54 may be provided by defining the medical powder storage chamber by way of only a cylindrical portion 52 of a medical powder storage cylindrical member 51 .
- the bottom face of the cylindrical fit hole of the medicator body is designed to be flat. In the same manner, such a construction can be applied to the other embodiments.
- the medical powder in the cylindrical fit hole can be atomized.
- the mixture of the incoming air and medical powder passes through the outflow air passageway and then flows towards within the inhalant port, and thus the patient can inhale the medical powder through the inhalant port into lungs of the patient.
- the inhalant medicator of the invention is constructed by two component parts, namely the medicator body and the medical powder storage cylindrical member, and also it is possible to open and close each of the air passageways with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, thereby reducing production costs, and consequently ensuring reduced economical burden of the patient.
- the inhalant medicator of the invention can be suitably used as a throwaway type.
- the patient can inhale a specified amount of medical powder into lungs. This enhances medical benefits of the powdered or granular medicines, and also enhances the reliability of the inhalant medicator.
- the inflow and outflow air passageways can be respectively opened or closed by means of the inflow outlet port and the outflow outlet port by rotating the medical powder storage cylindrical member relative to the medicator body while grasping the knob portion.
- the inflow air passageway and the outflow air passageway are respectively closed by the inflow outlet port and the outflow outlet port, it is possible to prevent the medical powder to flow out.
- the inflow and outflow air passageways can be respectively opened or closed through the inflow outlet port and the outflow outlet port by taking out or putting in the medical powder storage cylindrical member relative to the medicator body, while grasping the knob portion.
- the inflow air passageway and the outflow air passageway are respectively closed by the inflow outlet port and the outflow outlet port, it is possible to prevent the medical powder to flow out.
- the stopper means when operating the medical powder storage cylindrical member, can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other.
- the stopper means can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Nozzles (AREA)
Abstract
An inhalant medicator includes a medicator body 1 which is formed therein with a cylindrical fit hole 2, an inhalant port 3, an inflow air passageway 5, and an outflow air passageway 6, and a medical powder storage cylindrical member 8 which is installed or fitted into the cylindrical fit hole 2 in a manner so as to open or close the air passageways 5 and 6 with respect to a medical powder storage chamber 12. The inhalant medicator is constructed by two component parts, namely the medicator body 1 and the medical powder storage cylindrical member 8, thus ensuring simplified structure and reduced production costs. Additionally, powder-and-granular medicine or medical powder 16 is tightly encapsulated within the medical powder storage chamber 12 by means of the medical powder storage cylindrical member 8, thus preventing loss of flow of the medical powder 16.
Description
- The invention relates to an inhalant medicator suitable to prescribe granular or powdered medicines (medical powder) toward within lungs of a patient by way of breathing action of the patient.
- Generally, there are two medications of prescribing a medicine toward within lungs of an asthmatic patient, that is, one being a medication that a medicine is inhaled by way of a liquid aerosol atomizer, and the other being an inhalation treatment that granular or powdered medicines (which will be hereinafter referred to as “medical powder”) encapsulated in a capsule are inhaled.
- Of these medications for an asthmatic patient, an inhalant medicator used for an inhalation treatment where encapsulated medical powder is inhaled, has been disclosed in Japanese Patent Provisional Publication No. 7-313599.
- The inhalant medicator as disclosed in the above Japanese Patent Provisional Publication is generally comprised of a medicator body equipped at one axial end with a capsule housing hole and at the other axial end with an inhalant port, an inflow air passageway formed in the medicator body for flowing air into the capsule housing hole, an outflow air passageway formed in the medicator body for flowing medical powder stored in the capsule of the capsule housing hole together with airflown through the inflow air passageway into the inhalant port, pin insertion holes located at both sides of the capsule housing hole in the axial directions of the capsule housing hole and bored in the medicator body in such a manner as to extend in a radial direction of the medicator body for communicating each of the inflow and outflow air passageways, and a boring tool having pins insertable toward the capsule through the respective pin insertion holes for breaking through the capsule accommodated in the capsule housing hole.
- In such inhalant medicators, the capsule is accommodated in the capsule housing hole, and holes, communicating the internal space of the capsule with each of the air passageways, are pricked or punched by means of the boring tool. Under this condition, the patient draws his or her breath while taking the inhalant port in his or her mouse, and thus air is flown from the atmospheric side through the inflow air passageway into the capsule. The air flow carries and discharges the medical powder stored in the capsule through the outflow air passageway into the inhalant port. In this manner, the medical powder flowing out of the capsule can be inhaled through the inhalant port into the lungs of the patient.
- The conventional inhalant medicator described above, is constructed so that a capsule is inserted into a capsule housing hole of a medicator body, and the medical powder stored in the capsule is inhaled by pricking or punching holes in the capsules by way of a boring tool. For the reasons set forth above, there is the necessity for pin insertion holes and the boring tool. This increases the number of component parts, and induces a complicated structure. Thus, there are some problems, such as increased production costs and increased economical burden of a patient.
- Also, in recent years, there are another problems, such as sanitary problems and a throwaway type of medicators. In particular, in case of a pose of medicine to be taken only once, a medicator is not used continuously. In this case, a new medicator is used only once for each medication. A so-called throwaway type of medicators exists. Therefore, people can think about the use of the conventional medicator as a throwaway type. However, for the reasons set out above, this medicator is not suitable to use as a throwaway type.
- It is, therefore, in view of the previously-described disadvantages of the prior art, an object of the present invention to provide an inhalant medicator which is capable of reducing production costs by reducing the number of component parts and by simplifying its structure.
- In order to accomplish the aforementioned and other objects, according to the invention as claimed in
claim 1, an inhalant medicator comprises a medicator body formed with a cylindrical fit hole opening at one axial end and formed at the other axial end with an inhalant port, an inflow air passageway formed in the medicator body for supplying air into the cylindrical fit hole, an outflow air passageway formed in the medicator body for discharging air from the cylindrical fit hole into the inhalant port, and a medical powder storage cylindrical member having a cylindrical portion defining therein a medical powder storage hole whose internal space stores a medical powder and capable of opening and closing each of the inflow air passageway and the outflow air passageway with respect to the medical powder storage hole by external operation. - In the inhalant medicator as constructed above, under a condition where the inflow air passageway and the outflow air passageway are closed with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside via the air passageways. On the other hand, when the medical powder has to be inhaled, the inflow air passageway and the outflow air passageway are communicated with the medical powder storage hole by operating the medical powder storage cylindrical member. Under these conditions, the patient draws his or her breath while taking the inhalant port in his or her mouse, atmosphere flown into the inflow air passageway flows into the medical powder storage hole, taking the form of air flow. As a result of this, the medical powder in the medical powder storage hole can be atomized. Thus, in a blended condition of the medical powder with air flow, the mixture of the incoming air and medical powder passes through the outflow air passageway and then flows towards within the inhalant port, and then the mixture is inhaled through the inhalant port into lungs of the patient.
- The inhalant medicator of the invention is constructed by two component parts, namely the medicator body and the medical powder storage cylindrical member, and also it is possible to open and close each of the air passageways with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, thus ensuring a simple structure of the medicator. This reduces production costs. Additionally, even when the medical powder storage hole is filled with granular or powdered medicines in advance, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside.
- According to the invention as claimed in
claim 2, at least one medical powder diffusion chamber is formed in the medicator body and located between the cylindrical fit hole and the inhalant port for diffusing the medical powder flowing out of the outflow air passageway. - In the inhalant medicator as constructed above, when the patient draws his or her breath while taking the inhalant port in his or her mouse, the medical powder flowing from the medical powder storage hole via the outflow air passageway can be further diffused through the medical powder diffusion chamber, and thus the medical powder can flow into the inhalant port in a finely atomized fashion.
- According to the invention as claimed in
claim 3, the air passageway communicating with the medical powder diffusion chamber is formed to open to the medical powder diffusion chamber at an eccentric position in which the air passageway extends in a tangential direction of the medical powder diffusion chamber. - In the inhalant medicator as constructed above, when air flow passes through the inflow air passageway and then flows into the medical powder diffusion chamber, the inflow air passageway eccentrically arranged in the tangential direction of the medical powder diffusion chamber produces whirling flow within the medical powder diffusion chamber. Thus, even when granulated medicines; having a strong condensation property or a bad dispersion, are adhered or stuck to each other, it is possible to atomize the granulated medicines by virtue of the whirling flow.
- According to the invention as claimed in
claim 4, the medical powder storage cylindrical member is constructed by a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion. - In the inhalant medicator as constructed above, the inflow and outflow air passageways can be respectively opened or closed by means of the inflow outlet port and the outflow outlet port by rotating the medical powder storage cylindrical member relative to the medicator body while grasping the knob portion.
- According to the invention as claimed in
claim 5, the medical powder storage cylindrical member is constructed by a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion. - In the inhalant medicator as constructed above, the inflow and outflow air passageways can be respectively opened or closed through the inflow outlet port and the outflow outlet port by taking out or putting in the medical powder storage cylindrical member relative to the medicator body, while grasping the knob portion.
- According to the invention as claimed in
claim 6,a stopper means is provided between the medicator body and the medical powder storage cylindrical member for positioning the medical powder storage cylindrical member at a position where the inflow outlet port is communicated with the inflow air passageway and the outflow outlet port is communicated with the outflow air passageway when operating the medical powder storage cylindrical member. - In the inhalant medicator as constructed above, when operating the medical powder storage cylindrical member, the stopper means can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other. Thus, it is possible to easily and certainly open or close the inflow and outflow air passageways.
- FIG. 1 is a longitudinal cross-sectional view illustrating a first embodiment of an inhalant medicator made according to the invention.
- FIG. 2 is an enlarged lateral cross-sectional view illustrating a medicator body, a cylindrical portion, an inflow air passageway (an outflow air passageway), and others as viewed from the arrow indicated by II-II shown in FIG. 1.
- FIG. 3 is an enlarged lateral cross-sectional view illustrating a medicator body, an outflow air passageway, and others as viewed from the arrow indicated by III-III shown in FIG. 1.
- FIG. 4 is an enlarged perspective view illustrating the appearance of a medical powder storage cylindrical member.
- FIG. 5 is an enlarged perspective view illustrating an essential part of a stopper mechanism provided at the medicator body and the knob portion of the medical powder storage cylindrical member.
- FIG. 6 is an enlarged lateral cross-sectional view illustrating a state of the air passageway formed in the medicator body and the outlet port formed in the cylindrical portion of the medical powder storage cylindrical member, spaced to each other in the circumferential direction, as viewed from the same position as FIG. 2.
- FIG. 7 is a longitudinal cross-sectional view illustrating the inhalant medicator under a particular condition in which medical powders are inhaled, as viewed from the same position as FIG. 1.
- FIG. 8 is a longitudinal cross-sectional view illustrating a second embodiment of an inhalant medicator made according to the invention.
- FIG. 9 is a longitudinal cross-sectional view illustrating a third embodiment of an inhalant medicator made according to the invention.
- FIG. 10 is an enlarged lateral cross-sectional view illustrating the medicator body, a first outflow air passageway and others, as viewed from the arrow indicated by X-X shown in FIG. 9.
- FIG. 11 is an enlarged lateral cross-sectional view illustrating the medicator body, a second outflow air passageway and others, as viewed from the arrow indicated by XI-XI shown in FIG. 9.
- FIG. 12 is a longitudinal cross-sectional view illustrating the inhalant medicator under a particular condition in which a medical powder is inhaled, as viewed from the same position as FIG. 9.
- FIG. 13 is a longitudinal cross-sectional view illustrating a fourth embodiment of an inhalant medicator made according to the invention.
- FIG. 14 is an enlarged cross-sectional view illustrating an essential part of the inhalant medicator in an engaged state between a C-shaped groove of the cylindrical fit hole and an engaged protruded portion of the medical powder storage cylindrical member, as viewed from the arrow indicated by XIV-XIV shown in FIG. 9.
- FIG. 15 is a longitudinal cross-sectional view illustrating the inhalant medicator in an inhalation state of medical powder with the medical powder storage cylindrical member extracted from the medicator body, as viewed from the same position as FIG. 13.
- FIG. 16 is a longitudinal cross-sectional view illustrating an inhalant medicator corresponding to a first modification of the invention.
- FIG. 17 is a longitudinal cross-sectional view illustrating only a medical powder storage cylindrical member corresponding to a second modification of the invention.
- The embodiments of the inhalant medicator of the present invention will be hereinbelow described in detail in reference to the drawings attached hereto.
- Referring now to FIGS. 1 through 7, there is shown the first embodiment of the invention.
Reference sign 1 denotes a cylindrical medicator body constructing an essential part of the inhalant medicator. Themedicator body 1 is formed with a cylindricalfit hole 2 as described later, aninhalant port 3, aninflow air passageway 5, anoutflow air passageway 6, and others. - A portion denoted by
reference sign 2 is the cylindrical fit hole formed in themedicator body 1 at one axial end. The cylindricalfit hole 2 has an axially extending bore opening at the oneaxial end face 1A and having a circular shape in cross section and having a bottom. Thebottom portion 2A of the cylindrical fit hole is formed as a spherical surface. Also, thebottom portion 2A of the cylindricalfit hole 2 is formed with an annular recessedgroove 2B. The annular recessedgroove 2B is configured so that an annular protrudedportion 9A formed at the tip end portion of acylindrical portion 9 of a medical powder storagecylindrical member 8, which will be described later. - A portion denoted by
reference sign 3 is the inhalant port formed at the other axial end of themedicator body 1. Theinhalant port 3 is formed and configured in such a manner as to gradually diametrically enlarged in the other axial direction. Additionally, the inner part of theinhalant port 3 is formed with a medicalpowder diffusion chamber 4, which will be described later. - A portion denoted by
reference sign 4 is the medical powder diffusion chamber located between the cylindricalfit hole 2 and theinhalant port 3 and formed in themedicator body 1. The medicalpowder diffusion chamber 4 is formed as a cylindrical space axially extending toward theinhalant port 3, so that whirling flow is produced by way of air flow of air flowing through the inflow air passageway which will be described later. - Portions denoted by
reference signs medicator body 1. As shown in FIGS. 1 and 2, each of theinflow air passageways 5 is constructed by axially-extendingaxial passages 5A, SA located on the outer periphery of the cylindricalfit hole 2 and opening to the atmosphere at the oneaxial end face 1A, andradial passages axial passages 5A and extending in the radial direction of themedicator body 1 and opening to the cylindrical fit bore 2. - Portions denoted by
reference signs outflow air passageways 6 is constructed byradial air passageways medicator body 1 and opening to the cylindricalfit hole 2, andaxial passages radial passages 6A and extending in two opposite axial directions, and diffusionchamber inflow passages axial passages 6B and opening to thediffusion chamber 4. - The diffusion
chamber inflow passage 6C of theinflow air passageway 6, opening to the medicalpowder diffusion chamber 4, is formed so that its tip end portion opens at an eccentric position in which the inflow passage extends in the tangential direction of the medicalpowder diffusion chamber 4. As a result of this, air flow flowing through the diffusionchamber inflow passage 6C into the medicalpowder diffusion chamber 4 becomes changed or converted into whirling flow, thus finely atomizing a lump of granular orpowdered medicines 16 adhered to each other due to aggregation, condensation or the like. - Portions denoted by
reference signs fit hole 2 and formed in themedicator body 1. As shown in FIG. 3, each of theauxiliary air passageways 7 is provided at a position rotated 90 degrees with respect to therespective air passageways auxiliary air passageway 7 is constructed byaxial passages fit hole 2 and extending in the axial direction and opening to the atmosphere at the oneaxial end face 1A, and diffusionchamber inflow passages axial passages 7A and extending in the radial direction of themedicator body 1 and opening to the medicalpowder diffusion chamber 4. Each of theauxiliary air passageways 7 functions to avoid difficulty in breathing action by increasing a quantity of air flowing through the medicator during breathing action, and to strengthen the whirling flow within the medicalpowder diffusion chamber 4. - Hereupon, in the same manner as the diffusion
chamber inflow passage 6C of theoutflow air passageway 6 described previously, the diffusionchamber inflow passage 7B of theauxiliary air passageway 7 opening to the medicalpowder diffusion chamber 4 is formed so that its tip end portion opens at an eccentric position in which the inflow passage extends in the tangential direction of the medicalpowder diffusion chamber 4, thus producing the whirling flow within the medicalpowder diffusion chamber 4 by way of air flow flowing into the medicalpowder diffusion chamber 4. The whirling flow can finely atomize a lump of granular orpowdered medicines 16 adhered to each other due to aggregation, condensation or the like. - Next, a portion denoted by
reference sign 8 is a medical powder storage cylindrical member rotatably installed at the opening end of the cylindricalfit hole 2. As shown in FIG. 4, the medical powder storagecylindrical member 8 is mainly constructed by acylindrical portion 9 inserted and fitted into the cylindricalfit hole 2, and a disc-shapedknob portion 10 provided at the base portion of thecylindrical portion 9. The interior of thecylindrical portion 9 is formed as a medicalpowder storage hole 11 having a bottom and opening towards its tip end. Hereupon, the above medicalpowder storage hole 11 defines a medicalpowder storage chamber 12 capable of storing themedical powder 16 between the storage hole and thebottom portion 2A of the cylindricalfit hole 2 by way of fit of thecylindrical portion 9 into the cylindricalfit hole 2 of themedicator body 1. - Additionally, the previously-noted
cylindrical portion 9 is formed at its tip end portion with an annular protrudedportion 9A which is fitted into the annular recessedgroove 2B of the cylindricalfit hole 2. Fitted engagement between the annular recessedgroove 2B and the annular protrudedportion 9A prevents from the medical powder storagecylindrical member 8 from being fallen out. Furthermore, thecylindrical portion 9 is formed at a position corresponding to theradial passage 5B of theinflow air passageway 5 in the axial direction with aninflow outlet port 9B so that the inflow outlet port extends or penetrates in the radial direction, and is also formed at a position corresponding to theradial passage 6A of theoutflow air passageway 6 in the axial direction with anoutflow outlet port 9C so that the outflow outlet port extends or penetrates in the radial direction. - On the other hand, the
knob portion 10 is abutted-engagement with the oneaxial end face 1A of themedicator body 1 in a powder-tight fashion. As shown in FIGS. 4 and 5, the knob portion is formed on its outer periphery with aknurling portion 10A serving as a non-slip portion during rotary motion of the medical powder storagecylindrical member 8. Also, theknob portion 10 is formed withatmospheric outlet portions outlet ports cylindrical portion 9 in the circumferential direction and also corresponding to theaxial passage 5A of theinflow air passageway 5 and theaxial passage 7A of theauxiliary air passageway 7 in the radial direction, so that the atmospheric outlet portions extend or penetrate in the axial direction. - The medical powder storage
cylindrical member 8 closes the medicalpowder storage chamber 12 by rotating thecylindrical portion 9 relative to themedicator body 1 while grasping theknob portion 10 and therefore moving theair passageways outlet ports powder storage chamber 12 is fully closed. On the other hand, by establishing fluid communication between theair passageway 5 and theoutlet port 9B and fluid communication between theair passageway 6 and theoutlet port 9C, theair passageways - At this time, the atmospheric outlet ports l0B formed in the
knob portion 10 act to open or close theair passageways air passageways knob portion 10, it is possible to prevent dusts from flowing from the outside into theair passageways - A portion denoted by13 is a stopper mechanism serving as a stopper means provided between the
medicator body 1 and the medical powder storagecylindrical member 8. Thestopper mechanism 13 is constructed by apositioning groove 14 formed in the outer periphery of themedicator body 1 and a protrudedportion 15 located on the outer periphery of theknob portion 10 of the medical powdercylindrical member 8 and projected toward thepositioning groove 14. Also, thepositioning groove 14 is formed with a closed-position recessedportion 14A which is brought into engagement with the protrudedportion 15 at the closed position (see FIG. 6) at which theinflow air passageway 5 and theinflow outlet port 9B are offset to each other, theoutflow air passageway 6 and theoutflow outlet port 9C are offset to each other, and theauxiliary air passageway 7 and theatmospheric outlet port 10B are offset to each other, and an open-position recessedportion 14B which is brought into engagement with the protrudedportion 15 at the open position (see FIG. 2) where theair passageways respective outlet ports 9B, 9C. and 10B. As a result of this, thestopper mechanism 13 permits theair passageways respective outlet ports cylindrical member 8 relative to themedicator body 1. -
Reference sign 16 denotes medical powder stored in the cylindricalfit hole 2. Themedical powder 16 is formed as powdered or granulated medicines. Themedical powder 16 is charged into the medicalpowder storage chamber 12 at a stage where the medical powder storagecylindrical member 8 is installed on themedicator body 1. - The inhalant medicator of the embodiment is constructed as previously discussed. Hereinbelow described in detail are the operation of the inhalant medication through which the patient inhales the medical powder, and the flow of air and medical powder during inhalation.
- First, rotary operation of the medical powder storage
cylindrical member 8 relative to themedicator body 1 is made, so as to establish fluid communication between theinflow air passageway 5 and theinflow outlet port 9B, fluid communication between theoutflow air passageway 6 and theoutflow outlet port 9C, and fluid communication between theauxiliary air passageway 7 and theatmospheric outlet port 10B, and thus to ensure the open position. - Next, under this condition, the patient draws his or her breath while taking the
inhalant port 3 in his or her mouse. As a result of this, as can be seen from the arrow shown in FIG. 7, air (atmosphere) passes through theatmospheric outlet port 10B of theknob portion 10, theinflow air passageway 5, and theinflow outlet port 9B of thecylindrical portion 9, and then flows into the medicalpowder storage chamber 12. At this time, air flow flowing into the medicalpowder storage chamber 12 disperses and atomizes themedical powder 16 stored in the medicalpowder storage chamber 12. - However, there is a lump of
medical powder 16 existing in the internal space. Themedical powder 16 passes through theoutflow outlet port 9C of thecylindrical portion 9 and theoutflow air passageway 6, and then flows into the medicalpowder diffusion chamber 4. A lump ofmedical powder 16 can be diffused within the medicalpowder diffusion chamber 4 by way of whirling flow produced by the diffusionchamber inflow passages - In this manner, the
medical powder 16, finely atomized within the medicalpowder diffusion chamber 4, is discharged into theinhalant port 3. Thus, it is possible to prescribe the medical powder via the oral cavity and trachea of a patient into lungs of the patient by inhaling the medical powder discharged via theinhalant port 3 by way of breathing action of the patient. - As discussed above, according to the embodiment, the inhalant medicator can be constructed by two component parts, namely the
medicator body 1 and the medical powder storagecylindrical member 8, thus reducing the number of component parts, and ensuring more simplified inhalator structure and reduced production costs, in comparison with the conventional inhalant medicator. - Furthermore, it is possible to open or close the
inflow air passageway 5 and theoutflow air passageway 6 with respect to the medicalpowder storage chamber 12 by means of the medical powder storagecylindrical member 8. Thus, it is possible to tightly encapsulate themedical powder 16 within the medicalpowder storage chamber 12, thus preventing undesirable loss of flow ofmedical powder 16. - As appreciated from the above, even when the inhalant medicator of the embodiment is thrown away after the inhalant medicator has been used only once, it is possible to reduce an economical burden of the patient. Additionally, even when the medical
powder storage chamber 12 is filled withmedical powder 16 during assembling process, it is possible to prevent undesirable loss of flow ofmedical powders 16. Thus, the inhalant medicator of the embodiment can be used as a throwaway type. - On the one hand, the medical
powder diffusion chamber 4 is provided between the cylindricalfit hole 2 and theinhalant port 3. Therefore, it is possible to certainly finely atomize themedical powder 16. This ensures an enhanced inhalation efficiency ofmedical powder 16 and an enhanced reliability of the inhalant medicator. Additionally, it is possible to produce whirling flow within the medicalpowder diffusion chamber 4, thus more finely atomizingmedical powder 16. - Moreover, the
stopper mechanism 13 is provided between themedicator body 1 and the medical powder storagecylindrical member 8, for positioning the medical powder storage cylindrical member at either a closed position for prevention of loss of flow ofmedical powder 16 and an open position for medication, with rotary operation of the medical powder storagecylindrical member 8. Therefore, a series of operations for medication can be easily certainly achieved. Everyone can easily handle the inhalant medicator of the embodiment. - Hereunder described in reference to FIG. 8 is the second embodiment of the invention. In the second embodiment, the auxiliary air passageways used in the first embodiment are eliminated, and in lieu thereof the inflow and outflow air passageways are increased. In the second embodiment, the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the second embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
- A portion denoted by
reference sign 21 is a medicator body of the second embodiment. Portions denoted byreference signs medicator body 21. In the same manner as theinflow air passageway 5 of the first embodiment, each of theinflow air passageways 22 is constructed by anaxial passage 22A and aradial passage 22B. However, theinflow air passageway 22 of the second embodiment is different from theinflow air passageway 5 of the first embodiment, in that four passageways (only three passageways are shown in the drawing) spaced from each other in the circumferential direction are provided. - Portions denoted by
reference signs medicator body 21. In the same manner as theoutflow air passageway 6 of the first embodiment, each of theoutflow air passageways 23 is constructed by aradial passage 23A, anaxial passage 23B, and a diffusionchamber inflow passage 23C. However, theoutflow air passageway 23 of the second embodiment is different from theoutflow air passageway 6 of the first embodiment, in that four passageways (only three passageways are shown in the drawing) spaced from each other in the circumferential direction are provided. - The second embodiment as constructed above, can provide the same effects and operation as the first embodiment. In particular, in the second embodiment, the
auxiliary air passageways 7 used in the first embodiment are eliminated, and in lieu thereof the fourinflow air passageways 22 are provided, thus ensuring increased air flow of air flowing into the medicalpowder storage chamber 12. The increased air flow can effectively atomize themedical powder 16. - Hereinafter described in reference to FIGS. 9 and 12 is the third embodiment of the invention. The third embodiment is characterized in that a second medical powder diffusion chamber is provided between the cylindrical fit hole and the medical powder diffusion chamber. In the third embodiment, the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the third embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
- A portion denoted by
reference sign 31 is a medicator body of the third embodiment. Substantially in the same manner as themedicator body 1 of the first embodiment, themedicator body 31 is formed therein with a cylindricalfit hole 32, aninhalant port 33, and others. However, themedicator body 31 of the third embodiment has a first medicalpowder diffusion chamber 34 and a second medicalpowder diffusion chamber 35, both provided between the cylindricalfit hole 32 and theinhalant port 33. The medicator body of the third embodiment is different from themedicator body 1 of the first embodiment, in that as a whole the medicator body of the third embodiment is formed as a longer body. - Portions denoted by
reference signs inflow air passageway 5 of the first embodiment, each of theinflow air passageways 36 is constructed by anaxial passage 36A and aradial passage 36B. - Portions denoted by
reference signs outflow air passageways 37 is constructed byradial passages fit hole 32,axial passages radial passages 37A and extending in the axial direction, and diffusionchamber inflow passages axial passages 37B and opening to the first medicalpowder diffusion chamber 34. - Portions denoted by
reference signs outflow air passageways 38 is constructed by diffusionchamber outflow passages powder diffusion chamber 34,axial passages chamber outflow passages 38A and extending in the axial direction, and diffusionchamber inflow passages axial passages 38B and opening to the second medicalpowder diffusion chamber 35. - Portions denoted by
reference signs auxiliary air passageways 39 is constructed byaxial passages chamber inflow passages axial passages 39A and extending in the radial direction and opening to the first medicalpowder diffusion chamber 34. - Hereupon, as shown in FIG. 10, the diffusion
chamber inflow passage 37C of the firstinflow air passageway 37 opening to the first medicalpowder diffusion chamber 34 and the diffusionchamber inflow passage 39B of theauxiliary air passageway 39 are configured so that their tip end portions open at an eccentric position in which the inflow passage extends in the tangential direction of the first medicalpowder diffusion chamber 34. - As shown in FIG. 11, the diffusion
chamber outflow passage 38A of the secondinflow air passageway 38 opening to the first medicalpowder diffusion chamber 34 is configured, so that its tip end portion opens at an eccentric position in which the outflow passage extends in the tangential direction opposite to the diffusionchamber inflow passage 39B of theauxiliary air passageway 39, in order to facilitate the whirling flow produced within the first medicalpowder diffusion chamber 34 and passing through the diffusionchamber outflow passage 38A. - Furthermore, the diffusion
chamber inflow passage 38C of the secondoutflow air passageway 38 opening to the second medicalpowder diffusion chamber 35 opens at an eccentric position in which the inflow passage extends in the same tangential direction as the diffusionchamber inflow passage 37C of the firstoutflow air passageway 37 and the diffusionchamber inflow passage 39B of theauxiliary air passageway 39. - The third embodiment as constructed above, can provide the same effects and operation as the first embodiment. In particular, in the third embodiment, as a granular medicine diffusing chamber, two medical powder diffusion chambers, namely the first and second medical
powder diffusion chambers inhalant port 33 in his or her mouse, under a particular condition where themedical powder 16 includes granulated medicines having a strong condensation property and the granulated medicines are adhered to each other to form a lump of granulated medicines, as can be seen from FIG. 12, it is possible to break and atomize the lump of medical powder by means of the two medicalpowder diffusion chambers - Hereinafter described in reference to FIGS. 13 and 15 is the fourth embodiment of the invention. The fourth embodiment is characterized in that a medical powder storage cylindrical member is constructed by a cylindrical portion axially slidably fitted into the inner peripheral surface of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion. In the fourth embodiment, the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the fourth embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
- A portion denoted by
reference sign 41 is a medicator body of the fourth embodiment. A portion denoted byreference sign 42 is a cylindrical fit hole formed in themedicator body 41. The cylindricalfit hole 42 has an axially extending bore opening at oneaxial end 41A and having a circular shape in cross section and having a bottom. Thebottom portion 42A of the cylindrical fit hole is formed as a spherical surface. Also, thebottom portion 42A of the cylindricalfit hole 42 is formed with a C-shapedgroove 42B. As shown in FIG. 14, the C-shapedgroove 42B is configured in such a manner as to guide movably an engaged protrudedportion 44A of acylindrical portion 44 described later. - A portion denoted by
reference sign 43 is a medical powder storage cylindrical member of the fourth embodiment, installed on the cylindricalfit hole 42 so that the medical powder storage cylindrical member is capable of taking out or putting in with respect to the opening end of the cylindricalfit hole 42. Substantially in the same manner as the medical powder storagecylindrical member 8 of the first embodiment, the medical powder storagecylindrical member 43 is mainly constructed by acylindrical portion 44 inserted and fitted into the cylindricalfit hole 42, and a disc-shapedknob portion 45 provided at the base portion of thecylindrical portion 44. The interior of thecylindrical portion 44 is formed as a medicalpowder storage hole 46. A medicalpowder storage chamber 47 is defined between the medicalpowder storage hole 46 and thebottom portion 42A of the cylindricalfit hole 42. - However, the medical powder storage
cylindrical member 43 of the fourth embodiment is different from the medical powder storagecylindrical member 43 of the first embodiment, in that the engaged protruded portion 4A, fitted to the C-shapedgroove 42B of the cylindricalfit hole 42, is provided at the tip end portion of thecylindrical portion 44,inflow outlet port 44B andoutflow outlet port 44C are formed in thecylindrical portion 44 at positions at which the inflow and outflow outlet ports respectively communicate theradial passage 5B of theinflow air passageway 5 and theradial passage 6A of theoutflow air passageway 6 under a condition where thecylindrical portion 44 is extracted, and the atmospheric outlet ports used in the first embodiment are removed from theknob portion 45. - Hereupon, the C-shaped
groove 42B formed in the cylindricalfit hole 42 of themedicator body 41 and the engaged protrudedportion 44A formed in thecylindrical portion 44 of the medical powder storagecylindrical member 43 cooperate to each other to construct astopper mechanism 48 serving as a stopper means for positioning the medical powder storagecylindrical member 43 during taking-out/putting-in operation of the medical powder storagecylindrical member 43 with respect to themedicator body 41. - The inhalant medicator of the fourth embodiment is constructed as previously discussed. Hereinbelow described in detail is the operation of the inhalant medication through which the patient inhales the medical powder.
- In a state of the medicator prior to inhalant medication, as shown in FIG. 13, the
air passageways cylindrical portion 44, while the atmospheric side of each of theair passageways knob portion 45. - Under this condition, when the inhalant medication has to be made, the medical powder storage
cylindrical member 43 is rotated relative to themedicator body 41 in the direction indicated by the arrow A shown in FIGS. 13 and 14. Next, thecylindrical portion 44 of the medical powder storagecylindrical member 43 is extracted in the direction indicated by the arrow B. Thereafter, with rotary motion of the medical powder storagecylindrical member 43, returning the medical powder storagecylindrical member 43 to the direction indicated by the arrow C, as shown in FIG. 15, it is possible to position in such a manner as to establish fluid communication between theair passageway 5 and theinflow outlet port 44B and fluid communication between theair passageway 6 and theoutflow outlet port 44C. Under this condition, when the patient draws his or her breath while taking theinhalant port 3 in his or her mouse, themedical powder 16 can be inhaled. - The fourth embodiment as constructed above, can provide the same effects and operation as the first embodiment.
- As described above, in the third embodiment, the
auxiliary air passageways medicator body 31. However, the present invention is not limited to the particular embodiments shown and described herein. For instance, as can be seen from the first modification shown in FIG. 16, anotherauxiliary air passageways 39, 39 (only one passageway is shown in the drawing) intercommunicating the atmospheric side and the second medicalpowder diffusion chamber 35, may be formed in themedicator body 31, independently of theauxiliary air passageways powder diffusion chamber 34. - Additionally, in the first embodiment, the
inflow air passageway 5 is constructed by theaxial passage 5A and theradial passage 5B. In lieu thereof, as indicated by the two-dotted line shown in FIG. 1, aninflow air passageway 5′ is formed so that the inflow air passageway extends in the radial direction and opens to a curved surface of themedicator body 1. In the same manner, such a construction can be applied to the other embodiments. - Additionally, in the first, second, and fourth embodiments one medical
powder diffusion chamber 4 is provided, whereas in the second embodiment and the modification two medicalpowder diffusion chambers - On the other hand, as discussed above, in the first embodiment, the
medical powder 16 is encapsulated within the cylindricalfit hole 2 at a time when themedicator body 1 and the medical powder storagecylindrical member 8 are assembled to each other. In lieu thereof, themedical powder 16 may be charged into the cylindricalfit hole 2 just before the operation of inhalant medication. In the same manner, such a construction can be applied to the other embodiments. - Additionally, in each of the embodiments, the opening and closing of the
inflow air passageways respective knob portions cylindrical members - Additionally, in each of the embodiments, the
inflow air passageways outflow air passageways - Furthermore, in the first embodiment, the medical
powder storage chamber 12 is defined between thebottom portion 2A of the cylindricalfit hole 2 and the medicalpowder storage hole 11 by fitting thecylindrical portion 9 of the medicalpowder storage member 8 into the cylindricalfit hole 2 of themedicator body 1. The invention is not limited to the particular embodiments shown and described herein. For instance, as can be seen from the second modification shown in FIG. 17, a medicalpowder storage hole 54 may be provided by defining the medical powder storage chamber by way of only acylindrical portion 52 of a medical powder storagecylindrical member 51. In this case, it is preferable that the bottom face of the cylindrical fit hole of the medicator body is designed to be flat. In the same manner, such a construction can be applied to the other embodiments. - As explained above, according to the invention as claimed in
claim 1, under a condition where the inflow air passageway and the outflow air passageway are closed with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside via the air passageways. Also, when the medical powder has to be inhaled, the inflow air passageway and the outflow air passageway are opened to the medical powder storage hole by operating the medical powder storage cylindrical member. Under these conditions, the patient draws his or her breath while taking the inhalant port in his or her mouse, atmosphere flown into the inflow air passageway flows into the cylindrical fit hole, taking the form of air flow. As a result of this, the medical powder in the cylindrical fit hole can be atomized. Thus, in a blended condition of the medical powder with air flow, the mixture of the incoming air and medical powder passes through the outflow air passageway and then flows towards within the inhalant port, and thus the patient can inhale the medical powder through the inhalant port into lungs of the patient. - Additionally, the inhalant medicator of the invention is constructed by two component parts, namely the medicator body and the medical powder storage cylindrical member, and also it is possible to open and close each of the air passageways with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, thereby reducing production costs, and consequently ensuring reduced economical burden of the patient. In addition, even when the medical powder storage hole is filled with medical powder in advance, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside. Thus, the inhalant medicator of the invention can be suitably used as a throwaway type.
- According to the invention as claimed in
claim 2, the patient can inhale a specified amount of medical powder into lungs. This enhances medical benefits of the powdered or granular medicines, and also enhances the reliability of the inhalant medicator. - According to the invention as claimed in
claim 3, it is possible to produce or create whirling flow within the medical powder diffusion chamber by virtue of air flow passing through the air passageway and then flowing into the medical powder diffusion chamber. Even when the medical powder includes granulated medicines having a strong condensation property, it is possible to effectively diffuse and atomize the medical powder by way of the whirling flow, thus more remarkably enhancing an inhalation efficiency of the medical powder. - According to the invention as claimed in
claim 4, the inflow and outflow air passageways can be respectively opened or closed by means of the inflow outlet port and the outflow outlet port by rotating the medical powder storage cylindrical member relative to the medicator body while grasping the knob portion. Thus, under a condition where the inflow air passageway and the outflow air passageway are respectively closed by the inflow outlet port and the outflow outlet port, it is possible to prevent the medical powder to flow out. - According to the invention as claimed in
claim 5, the inflow and outflow air passageways can be respectively opened or closed through the inflow outlet port and the outflow outlet port by taking out or putting in the medical powder storage cylindrical member relative to the medicator body, while grasping the knob portion. Thus, under a condition where the inflow air passageway and the outflow air passageway are respectively closed by the inflow outlet port and the outflow outlet port, it is possible to prevent the medical powder to flow out. - According to the invention as claimed in
claim 6, when operating the medical powder storage cylindrical member, the stopper means can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other. Thus, it is possible to easily and certainly open or close the inflow and outflow air passageways, thus ensuring enhanced operability or easy manipulation.
Claims (11)
1. An inhalant medicator comprising:
a medicator body formed with a cylindrical fit hole opening at one axial end and formed at the other axial end with an inhalant port;
an inflow air passageway formed in the medicator body for supplying air into the cylindrical fit hole;
an outflow air passageway formed in the medicator body for discharging air from the cylindrical fit hole into the inhalant port; and
a medical powder storage cylindrical member having a cylindrical portion defining therein a medical powder storage hole whose internal space stores a medical powder and capable of opening and closing each of the inflow air passageway and the outflow air passageway with respect to the medical powder storage hole by external operation.
2. The inhalant medicator as claimed in claim 1 , wherein at least one medical powder diffusion chamber is formed in the medicator body and located between the cylindrical fit hole and the inhalant port for diffusing the medical powder flowing out of the outflow air passageway.
3. The inhalant medicator as claimed in claim 2 , wherein the air passageway communicating with the medical powder diffusion chamber is formed to open to the medical powder diffusion chamber at an eccentric position in which the air passageway extends in a tangential direction of the medical powder diffusion chamber.
4. The inhalant medicator as claimed in claim 1 , wherein the medical powder storage cylindrical member comprises a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
5. The inhalant medicator as claimed in claim 2 , wherein the medical powder storage cylindrical member comprises a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
6. The inhalant medicator as claimed in claim 3 , wherein the medical powder storage cylindrical member comprises a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
7. The inhalant medicator as claimed in claim 1 , wherein the medical powder storage cylindrical member comprises a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
8. The inhalant medicator as claimed in claim 2 , wherein the medical powder storage cylindrical member comprises a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
9. The inhalant medicator as claimed in claim 3 , wherein the medical powder storage cylindrical member comprises a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
10. The inhalant medicator as claimed in claim 4 , wherein a stopper means is provided between the medicator body and the medical powder storage cylindrical member for positioning the medical powder storage cylindrical member at a position where the inflow outlet port is communicated with the inflow air passageway and the outflow outlet port is communicated with the outflow air passageway when operating the medical powder storage cylindrical member.
11. The inhalant medicator as claimed in claim 7 , wherein a stopper means is provided between the medicator body and the medical powder storage cylindrical member for positioning the medical powder storage cylindrical member at a position where the inflow outlet port is communicated with the inflow air passageway and the outflow outlet port is communicated with the outflow air passageway when operating the medical powder storage cylindrical member.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/998,418 US20020033177A1 (en) | 1999-01-27 | 2001-12-03 | Inhalant medicator |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11-19145 | 1999-01-27 | ||
JP11019145A JP2000217917A (en) | 1999-01-27 | 1999-01-27 | Inhaler type medicine administration tool |
US09/623,478 US6371111B1 (en) | 1999-01-27 | 1999-12-27 | Inhalation type drug dispenser |
US09/998,418 US20020033177A1 (en) | 1999-01-27 | 2001-12-03 | Inhalant medicator |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/623,478 Continuation US6371111B1 (en) | 1999-01-27 | 1999-12-27 | Inhalation type drug dispenser |
PCT/JP1999/007305 Continuation WO2000044426A1 (en) | 1999-01-27 | 1999-12-27 | Inhalation type drug dispenser |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020033177A1 true US20020033177A1 (en) | 2002-03-21 |
Family
ID=11991291
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/623,478 Expired - Fee Related US6371111B1 (en) | 1999-01-27 | 1999-12-27 | Inhalation type drug dispenser |
US09/998,418 Abandoned US20020033177A1 (en) | 1999-01-27 | 2001-12-03 | Inhalant medicator |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/623,478 Expired - Fee Related US6371111B1 (en) | 1999-01-27 | 1999-12-27 | Inhalation type drug dispenser |
Country Status (5)
Country | Link |
---|---|
US (2) | US6371111B1 (en) |
EP (1) | EP1068874B1 (en) |
JP (1) | JP2000217917A (en) |
DE (1) | DE69929539T2 (en) |
WO (1) | WO2000044426A1 (en) |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6595210B2 (en) * | 2000-11-27 | 2003-07-22 | Unisia Jecs Corporation | Inhalator for administering powder composition |
WO2005084735A1 (en) * | 2004-03-05 | 2005-09-15 | Boehringer Ingelheim International Gmbh | Powder inhaler comprising a multi-channel nozzle |
WO2005089843A1 (en) * | 2004-03-18 | 2005-09-29 | Roberto Oliva | Inhaler for preparations in powder form |
WO2005113043A1 (en) * | 2004-05-19 | 2005-12-01 | Cipla Limited | Medicament inhaler device |
WO2005118035A1 (en) * | 2004-05-28 | 2005-12-15 | Quadrant Technologies Limited | Unit dose dry powder inhales |
US20070060868A1 (en) * | 2003-10-09 | 2007-03-15 | Bioactis Limited | Device to deliver a powdery medicine into nasal cavity |
EP1778322A1 (en) * | 2004-07-26 | 2007-05-02 | 1355540 Ontario Inc. | Powder inhaler featuring reduced compaction inhaler |
US20070272763A1 (en) * | 2004-10-06 | 2007-11-29 | Boehringer Ingelheim International Gmbh | Dispensing Device, Storage Device and Method for Dispensing Powder |
WO2008001132A1 (en) | 2006-06-27 | 2008-01-03 | Brintech International Limited | Inhaler |
US20090235930A1 (en) * | 2004-05-28 | 2009-09-24 | Young Matthew E | Unit dose dry powder inhaler |
CN102631736A (en) * | 2011-02-14 | 2012-08-15 | 中国人民解放军军事医学科学院毒物药物研究所 | Dry powder suction device |
US20120211007A1 (en) * | 2002-04-09 | 2012-08-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaler for the administration of an anticholinergic |
US9192675B2 (en) | 2008-06-13 | 2015-11-24 | Mankind Corporation | Dry powder inhaler and system for drug delivery |
US9283193B2 (en) | 2005-09-14 | 2016-03-15 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US9364436B2 (en) | 2011-06-17 | 2016-06-14 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9610351B2 (en) | 2011-10-24 | 2017-04-04 | Mannkind Corporation | Methods and compositions for treating pain |
US9630930B2 (en) | 2009-06-12 | 2017-04-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
US9655850B2 (en) | 2008-12-29 | 2017-05-23 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9662461B2 (en) | 2008-06-13 | 2017-05-30 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9675674B2 (en) | 2004-08-23 | 2017-06-13 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US9700690B2 (en) | 2002-03-20 | 2017-07-11 | Mannkind Corporation | Inhalation apparatus |
US9706944B2 (en) | 2009-11-03 | 2017-07-18 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
US9796688B2 (en) | 2004-08-20 | 2017-10-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9801925B2 (en) | 1999-06-29 | 2017-10-31 | Mannkind Corporation | Potentiation of glucose elimination |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US9943571B2 (en) | 2008-08-11 | 2018-04-17 | Mannkind Corporation | Use of ultrarapid acting insulin |
US9983108B2 (en) | 2009-03-11 | 2018-05-29 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US10130581B2 (en) | 2006-02-22 | 2018-11-20 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10342938B2 (en) | 2008-06-13 | 2019-07-09 | Mannkind Corporation | Dry powder drug delivery system |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US10625034B2 (en) | 2011-04-01 | 2020-04-21 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2365777A (en) * | 2000-05-16 | 2002-02-27 | Norton Healthcare Ltd | Drug delivery device for airborne medicament |
FI20002363A0 (en) * | 2000-10-27 | 2000-10-27 | Orion Yhtymae Oyj | powder inhaler |
FI20011317A0 (en) * | 2001-06-20 | 2001-06-20 | Orion Corp | The powder inhaler |
GB0227128D0 (en) * | 2002-11-20 | 2002-12-24 | Glaxo Group Ltd | A capsule |
GB0303870D0 (en) * | 2003-02-20 | 2003-03-26 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
PL1610850T3 (en) | 2003-04-09 | 2012-11-30 | Novartis Ag | Aerosolization apparatus with air inlet shield |
US8869794B1 (en) | 2003-04-09 | 2014-10-28 | Novartis Pharma Ag | Aerosolization apparatus with capsule puncturing member |
DE102004041524B4 (en) * | 2004-08-27 | 2013-03-21 | Sanofi Sa | Inhaler for powdery, in particular medicinal substances |
PL370285A1 (en) * | 2004-09-23 | 2006-04-03 | Glaxosmithkline Pharmaceuticals Spółka Akcyjna | Powder inhaler |
JP2006130143A (en) * | 2004-11-08 | 2006-05-25 | Hitachi Ltd | Inhalation administration device and medicine cartridge |
CN100431634C (en) * | 2005-04-04 | 2008-11-12 | 陈庆堂 | Dry powder aerosolizing inhalator |
AU2013205495B2 (en) * | 2006-02-17 | 2015-11-26 | Sanofi Sa | Dispersing unit |
DE102006007495A1 (en) | 2006-02-17 | 2007-08-23 | Siegfried Generics International Ag | Dispersion unit e.g. for medical powder inhalator and aerosol dispersion, uses annular guide chamber to direct entering powder flow in mainly radial direction |
WO2008101992A1 (en) * | 2007-02-21 | 2008-08-28 | Novo Nordisk A/S | Aerosol generating device with air flow control |
JP4963084B2 (en) * | 2007-05-31 | 2012-06-27 | 株式会社吉野工業所 | Suction dispenser |
IN2014DN06108A (en) * | 2011-12-16 | 2015-08-14 | Indosys Ltd | |
EP2944343A1 (en) * | 2014-05-15 | 2015-11-18 | AstraZeneca AB | Dry powder inhaler |
ES2760943T3 (en) * | 2016-05-23 | 2020-05-18 | Presspart Mfg Ltd | Dry powder inhaler |
KR20210117266A (en) * | 2019-01-14 | 2021-09-28 | 필립모리스 프로덕츠 에스.에이. | dry powder inhaler |
IT202100024582A1 (en) * | 2021-09-24 | 2023-03-24 | Bazzica Eng S R L | INHALER DEVICE AND INHALATION SYSTEM INCLUDING SAME |
WO2023047358A1 (en) * | 2021-09-24 | 2023-03-30 | Bazzica Engineering S.R.L. | Dry powder inhaler |
IT202200019479A1 (en) | 2022-09-22 | 2024-03-22 | Bazzica Eng S R L | DRY POWDER INHALER |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4175556A (en) * | 1978-04-07 | 1979-11-27 | Freezer Winthrop J | Inhaler with flow-through cap |
EP0005585B1 (en) * | 1978-05-03 | 1981-08-12 | FISONS plc | Inhalation device |
SE448277B (en) * | 1985-04-12 | 1987-02-09 | Draco Ab | INDICATOR DEVICE WITH A DOSAGE DEVICE FOR MEDICINAL PRODUCTS |
AT384552B (en) * | 1985-08-01 | 1987-12-10 | Hurka Wilhelm | INHALATION DEVICE FOR DOSING AND DISTRIBUTING SOLID BODIES INTO THE BREATHING AIR |
US5176132A (en) * | 1989-05-31 | 1993-01-05 | Fisons Plc | Medicament inhalation device and formulation |
FI84698C (en) * | 1989-06-16 | 1992-01-10 | Huhtamaeki Oy | ANORDINATION FOR FINANCING OF AGGLOMERIA AV EN ENKELDOS AV ETT LAEKEMEDELPREPARAT I PULVERFORM. |
GB9027234D0 (en) * | 1990-12-15 | 1991-02-06 | Harris Pharma Ltd | An inhalation device |
DE59107894D1 (en) * | 1991-03-21 | 1996-07-11 | Ritzau Pari Werk Gmbh Paul | Nebulizers, in particular for use in devices for inhalation therapy |
US5243970A (en) * | 1991-04-15 | 1993-09-14 | Schering Corporation | Dosing device for administering metered amounts of powdered medicaments to patients |
DE4211475A1 (en) * | 1991-12-14 | 1993-06-17 | Asta Medica Ag | POWDER INHALATOR |
US5394868A (en) * | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
SE9302550D0 (en) * | 1993-07-30 | 1993-07-30 | Ernst Hoerlin | POWDER INHALES |
JP3372105B2 (en) * | 1994-05-26 | 2003-01-27 | 株式会社日立ユニシアオートモティブ | Inhalation type dispenser |
JP3388896B2 (en) | 1994-08-08 | 2003-03-24 | 株式会社日立ユニシアオートモティブ | Inhalation type dispenser |
JPH0889576A (en) | 1994-09-27 | 1996-04-09 | Unisia Jecs Corp | Inhalation type medication device |
US5901703A (en) | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
JP3308425B2 (en) | 1995-03-10 | 2002-07-29 | 株式会社ユニシアジェックス | Nasal administration device |
JP3320261B2 (en) | 1995-06-01 | 2002-09-03 | 株式会社ユニシアジェックス | Inhaler type dispenser |
JP3434396B2 (en) | 1995-06-30 | 2003-08-04 | 株式会社日立ユニシアオートモティブ | Nasal administration device |
JP3317823B2 (en) | 1995-08-11 | 2002-08-26 | 株式会社ユニシアジェックス | Dosing device |
JP3317827B2 (en) | 1995-10-09 | 2002-08-26 | 株式会社ユニシアジェックス | Dosing device |
US5699789A (en) * | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
JP3328132B2 (en) | 1996-03-21 | 2002-09-24 | 株式会社ユニシアジェックス | Inhaler type dispenser |
JPH09253208A (en) | 1996-03-21 | 1997-09-30 | Unisia Jecs Corp | Medicator for nasal cavity |
ES2205210T3 (en) * | 1996-04-29 | 2004-05-01 | Quadrant Technologies Ltd. | INHALATION PROCEDURES FOR DRY POWDER. |
SE9700940D0 (en) * | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhales IV |
JP3530004B2 (en) | 1998-02-06 | 2004-05-24 | 株式会社日立ユニシアオートモティブ | Inhalation type dispenser |
-
1999
- 1999-01-27 JP JP11019145A patent/JP2000217917A/en active Pending
- 1999-12-27 US US09/623,478 patent/US6371111B1/en not_active Expired - Fee Related
- 1999-12-27 DE DE69929539T patent/DE69929539T2/en not_active Expired - Fee Related
- 1999-12-27 EP EP99961391A patent/EP1068874B1/en not_active Expired - Lifetime
- 1999-12-27 WO PCT/JP1999/007305 patent/WO2000044426A1/en active IP Right Grant
-
2001
- 2001-12-03 US US09/998,418 patent/US20020033177A1/en not_active Abandoned
Cited By (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9801925B2 (en) | 1999-06-29 | 2017-10-31 | Mannkind Corporation | Potentiation of glucose elimination |
US20030188747A1 (en) * | 2000-11-27 | 2003-10-09 | Unisia Jecs Corporation | Inhalator, a powder composition and a process for administering the powder composition using inhalators |
US6595210B2 (en) * | 2000-11-27 | 2003-07-22 | Unisia Jecs Corporation | Inhalator for administering powder composition |
US9700690B2 (en) | 2002-03-20 | 2017-07-11 | Mannkind Corporation | Inhalation apparatus |
US20160279356A1 (en) * | 2002-04-09 | 2016-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaler for the administration of an anticholinergic |
US20140116435A1 (en) * | 2002-04-09 | 2014-05-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaler for the administration of an anticholinergic |
US20120211007A1 (en) * | 2002-04-09 | 2012-08-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaler for the administration of an anticholinergic |
US20070060868A1 (en) * | 2003-10-09 | 2007-03-15 | Bioactis Limited | Device to deliver a powdery medicine into nasal cavity |
US7722566B2 (en) * | 2003-10-09 | 2010-05-25 | Shin Nippon Biomedical Laboratories, Ltd. | Device to deliver a powdery medicine into nasal cavity |
WO2005084735A1 (en) * | 2004-03-05 | 2005-09-15 | Boehringer Ingelheim International Gmbh | Powder inhaler comprising a multi-channel nozzle |
US20050263151A1 (en) * | 2004-03-05 | 2005-12-01 | Boehringer Ingelheim International Gmbh | Powder inhaler having a nozzle with a plurality of channels |
US7984713B2 (en) | 2004-03-05 | 2011-07-26 | Boehringer Ingelheim International Gmbh | Powder inhaler having a nozzle with a plurality of channels |
WO2005089843A1 (en) * | 2004-03-18 | 2005-09-29 | Roberto Oliva | Inhaler for preparations in powder form |
US20070277821A1 (en) * | 2004-03-18 | 2007-12-06 | Roberto Oliva | Inhaler For Preparations In Powder Form |
US8302601B2 (en) | 2004-03-18 | 2012-11-06 | Roberto Oliva | Inhaler for preparations in powder form |
WO2005113043A1 (en) * | 2004-05-19 | 2005-12-01 | Cipla Limited | Medicament inhaler device |
US20090235931A1 (en) * | 2004-05-28 | 2009-09-24 | Young Matthew E | Unit dose dry powder inhaler |
US20090235930A1 (en) * | 2004-05-28 | 2009-09-24 | Young Matthew E | Unit dose dry powder inhaler |
US7556035B2 (en) | 2004-05-28 | 2009-07-07 | Quadrant Technologies Limited | Unit dose dry powder inhaler |
WO2005118035A1 (en) * | 2004-05-28 | 2005-12-15 | Quadrant Technologies Limited | Unit dose dry powder inhales |
US20080142006A1 (en) * | 2004-07-26 | 2008-06-19 | 1355540 Ontario Inc. | Powder Inhaler Featuring Reduced Compaction Inhaler |
US8171930B2 (en) * | 2004-07-26 | 2012-05-08 | 135540 Ontario Inc. | Powder inhaler featuring reduced compaction inhaler |
EP1778322A4 (en) * | 2004-07-26 | 2011-01-19 | 1355540 Ontario Inc | Powder inhaler featuring reduced compaction inhaler |
EP1778322A1 (en) * | 2004-07-26 | 2007-05-02 | 1355540 Ontario Inc. | Powder inhaler featuring reduced compaction inhaler |
US9796688B2 (en) | 2004-08-20 | 2017-10-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US10130685B2 (en) | 2004-08-23 | 2018-11-20 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US9675674B2 (en) | 2004-08-23 | 2017-06-13 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US20070272763A1 (en) * | 2004-10-06 | 2007-11-29 | Boehringer Ingelheim International Gmbh | Dispensing Device, Storage Device and Method for Dispensing Powder |
US9283335B2 (en) * | 2004-10-06 | 2016-03-15 | Boehringer Ingelheim International Gmbh | Dispensing device, storage device and method for dispensing powder |
US9089658B2 (en) * | 2004-10-06 | 2015-07-28 | Boehringer Ingelheim International Gmbh | Dispensing device, storage device and method for dispensing powder |
US20120222675A1 (en) * | 2004-10-06 | 2012-09-06 | Boehringer Ingeleim International Gmbh | Dispensing device, storage device and method for dispensing powder |
US9283193B2 (en) | 2005-09-14 | 2016-03-15 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US10143655B2 (en) | 2005-09-14 | 2018-12-04 | Mannkind Corporation | Method of drug formulation |
US9446001B2 (en) | 2005-09-14 | 2016-09-20 | Mannkind Corporation | Increasing drug affinity for crystalline microparticle surfaces |
US9717689B2 (en) | 2005-09-14 | 2017-08-01 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US10130581B2 (en) | 2006-02-22 | 2018-11-20 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US8201555B2 (en) | 2006-06-27 | 2012-06-19 | Brintech International Limited | Inhaler |
US20090308388A1 (en) * | 2006-06-27 | 2009-12-17 | Brindra Paul Singh Chawla | Inhaler |
WO2008001132A1 (en) | 2006-06-27 | 2008-01-03 | Brintech International Limited | Inhaler |
US9446133B2 (en) | 2008-06-13 | 2016-09-20 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10342938B2 (en) | 2008-06-13 | 2019-07-09 | Mannkind Corporation | Dry powder drug delivery system |
US9662461B2 (en) | 2008-06-13 | 2017-05-30 | Mannkind Corporation | Dry powder drug delivery system and methods |
US10751488B2 (en) | 2008-06-13 | 2020-08-25 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10201672B2 (en) | 2008-06-13 | 2019-02-12 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9192675B2 (en) | 2008-06-13 | 2015-11-24 | Mankind Corporation | Dry powder inhaler and system for drug delivery |
US9511198B2 (en) | 2008-06-13 | 2016-12-06 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9339615B2 (en) | 2008-06-13 | 2016-05-17 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10675421B2 (en) | 2008-06-20 | 2020-06-09 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9943571B2 (en) | 2008-08-11 | 2018-04-17 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10172850B2 (en) | 2008-12-29 | 2019-01-08 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9655850B2 (en) | 2008-12-29 | 2017-05-23 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9983108B2 (en) | 2009-03-11 | 2018-05-29 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US9630930B2 (en) | 2009-06-12 | 2017-04-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
US9706944B2 (en) | 2009-11-03 | 2017-07-18 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
CN102631736A (en) * | 2011-02-14 | 2012-08-15 | 中国人民解放军军事医学科学院毒物药物研究所 | Dry powder suction device |
US10625034B2 (en) | 2011-04-01 | 2020-04-21 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
US10130709B2 (en) | 2011-06-17 | 2018-11-20 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9364436B2 (en) | 2011-06-17 | 2016-06-14 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US10258664B2 (en) | 2011-10-24 | 2019-04-16 | Mannkind Corporation | Methods and compositions for treating pain |
US9610351B2 (en) | 2011-10-24 | 2017-04-04 | Mannkind Corporation | Methods and compositions for treating pain |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
Also Published As
Publication number | Publication date |
---|---|
DE69929539D1 (en) | 2006-04-06 |
DE69929539T2 (en) | 2006-08-10 |
JP2000217917A (en) | 2000-08-08 |
EP1068874B1 (en) | 2006-01-18 |
US6371111B1 (en) | 2002-04-16 |
WO2000044426A1 (en) | 2000-08-03 |
EP1068874A4 (en) | 2004-08-11 |
EP1068874A1 (en) | 2001-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6371111B1 (en) | Inhalation type drug dispenser | |
EP1475115B1 (en) | Dry powder inhaler | |
US5752505A (en) | Inhalation-type medicine delivery device | |
US6408846B1 (en) | Inhalation type drug dispenser | |
EP0973571B1 (en) | Inhalant medicator | |
EP0898978B1 (en) | Suction type medicator | |
EP1464356B1 (en) | Inhalator | |
NZ540936A (en) | Inhalation device for transpulmonary administration | |
US6341605B1 (en) | Inhalant medicator | |
JP3328131B2 (en) | Inhaler type dispenser | |
JP3845530B2 (en) | Inhaler | |
JPH09322938A (en) | Inhalation type medicator | |
JP3315031B2 (en) | Dosing device | |
JP2001161788A (en) | Blister pack | |
JP2000217920A (en) | Inhaler type medicine administration tool | |
JP3547612B2 (en) | Inhalation type dispenser | |
JP3434402B2 (en) | Dosing device | |
JPH1028735A (en) | Dosing device for nasal cavity | |
JPH09253209A (en) | Inhalation type medicator | |
JPH09253211A (en) | Inhalation type medicator | |
JPH09140792A (en) | Medicator | |
JPH11267213A (en) | Inhalation type medicine administer | |
JP2000217918A (en) | Inhaler type medicine administration tool | |
JPH09182792A (en) | Medicator | |
JPH09248341A (en) | Chemical administration device for nostril |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |